Civic Intelligence

The Jack and Jt Snow Scientific Research Foundation

990 • Fiscal year 2016 • EIN 45-5308117

Jan 01, 2016 to Dec 31, 2016

Clayton, MO
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

64th percentile

0.01x

Higher debt load relative to assets than 64% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Liabilities / Revenue

61st percentile

0.01x

Higher debt load relative to revenue than 61% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Net Margin

15th percentile

-23%

Higher net margin than 15% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

13th percentile

-36%

Faster asset growth than 13% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Revenue Growth

18th percentile

-28%

Faster revenue growth than 18% of similar nonprofits.

2016 filings • 501(c)3 • <$500k nonprofits • Annualized from 2015 to 2016

Assets

Down

$148,009

Down $83,780 (-36%) from 2015

Net Assets

Down

$145,836

Down $84,144 (-37%) from 2015

Liabilities

Up

$2,173

Up $364 (+20%) from 2015

Revenue

Down

$368,035

Down $141,699 (-28%) from 2015

Expenses

Down

$452,179

Down $20,233 (-4.3%) from 2015

Net Income

Down

-$84,144

Down $121,466 (-325%) from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.0M$500K$0-$500KAssets 2013: $89,327Liabilities 2013: $0Net Assets 2013: $89,3272013Assets 2014: $198,161Liabilities 2014: $5,503Net Assets 2014: $192,6582014Assets 2015: $231,789Liabilities 2015: $1,809Net Assets 2015: $229,9802015Assets 2016: $148,009Liabilities 2016: $2,173Net Assets 2016: $145,8362016Assets 2017: $152,698Liabilities 2017: $245Net Assets 2017: $152,4532017Assets 2018: $76,306Liabilities 2018: $6,780Net Assets 2018: $69,5262018Assets 2019: $170,702Liabilities 2019: $11,188Net Assets 2019: $159,5142019Assets 2020: $209,369Liabilities 2020: $8,014Net Assets 2020: $201,3552020Assets 2021: $336,955Liabilities 2021: $969Net Assets 2021: $335,9862021Assets 2022: $351,722Liabilities 2022: $894Net Assets 2022: $350,8282022Assets 2023: $603,694Liabilities 2023: $304Net Assets 2023: $603,3902023Assets 2024: $972,917Liabilities 2024: -$54Net Assets 2024: $972,9712024

Highlighted filing

2016

Assets$148,009
Liabilities$2,173
Net Assets$145,836

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$800K$600K$400K$200K$0-$200KRevenue 2013: $101,497Expenses 2013: $39,840Net Income 2013: $61,6572013Revenue 2014: $270,469Expenses 2014: $167,138Net Income 2014: $103,3312014Revenue 2015: $509,734Expenses 2015: $472,412Net Income 2015: $37,3222015Revenue 2016: $368,035Expenses 2016: $452,179Net Income 2016: -$84,1442016Revenue 2017: $214,512Expenses 2017: $207,895Net Income 2017: $6,6172017Revenue 2018: $176,133Expenses 2018: $259,060Net Income 2018: -$82,9272018Revenue 2019: $259,079Expenses 2019: $169,091Net Income 2019: $89,9882019Revenue 2020: $171,082Expenses 2020: $129,241Net Income 2020: $41,8412020Revenue 2021: $268,612Expenses 2021: $133,981Net Income 2021: $134,6312021Revenue 2022: $297,516Expenses 2022: $282,674Net Income 2022: $14,8422022Revenue 2023: $477,435Expenses 2023: $224,873Net Income 2023: $252,5622023Revenue 2024: $607,564Expenses 2024: $237,983Net Income 2024: $369,5812024

Highlighted filing

2016

Revenue$368,035
Expenses$452,179
Net Income-$84,144
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

The snow foundation is a collective voice for wolfram syndrome patients, working towards a cure for wolfram syndrome and developing novel therapies for diabetes, vision loss, hearing loss, and neurodegeneration.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings